Laboratory Medicine ›› 2025, Vol. 40 ›› Issue (10): 965-971.DOI: 10.3969/j.issn.1673-8640.2025.10.006

Previous Articles     Next Articles

Roles of serum cholinesterase,galectin-3 combined with cardiac function indicators for the prognosis evaluation of ADHF patients

ZHAO Haixia1, AN Yingbo2   

  1. 1 Outpatient DepartmentWest China Hospital,Sichuan UniversityChengdu 610041,Sichuan, China
    2 Department of EmergencyBeijing Haidian Hospital,Haidian District of Peking University Third HospitalBeijing 100080, China
  • Received:2024-03-19 Revised:2025-01-16 Online:2025-10-30 Published:2025-11-07

Abstract:

Objective To evaluate the prognosis of patients with acute decompensated heart failure (ADHF) by the combination of serum cholinesterase,galectin-3 and cardiac function indicators. Methods From August 2020 to August 2022,133 patients with ADHF at West China Hospital of Sichuan University and Beijing Haidian Hospital were enrolled. The 3-month and 1-year post-treatment periods were set as time points for short-term and long-term prognosis assessment. The patients were classified into poor short-term prognosis group,poor long-term prognosis group and good prognosis group. The differences of serum cholinesterase,galectin-3,N-terminal B-type natriuretic peptide (NT-proBNP),cardiac troponin I(cTnI)and left ventricular ejection fraction(LVEF)were compared. Multivariate Logistic regression analysis was used to evaluate the risk factors for poor short-term prognosis and poor long-term prognosis of the patients. Receiver operating characteristic(ROC)curve was used to analyze the role of combined determination of serum cholinesterase,galectin-3,NT-proBNP,cTnI and LVEF in predicting poor short-term and long-term prognosis in patients with ADHF. Results The serum cholinesterase levels and LVEF in short-term poor prognosis group and long-term poor prognosis group were both lower than those in good prognosis group(P<0.001),while the levels of galectin-3,NT-proBNP and cTnI were all higher than those in good prognosis group (P<0.001). Renal function insufficiency,liver function insufficiency and acute coronary syndrome were independent risk factors for poor short-term prognosis(P<0.01),while renal function insufficiency and liver function insufficiency were independent risk factors for poor long-term prognosis(P<0.05). Decreased serum cholinesterase,decreased LVEF,elevated galectin-3,elevated NT-proBNP and elevated cTnI were independent risk factors for poor short-term prognosis and poor long-term prognosis,respectively(P<0.05). The areas under curves(AUC) for the single determinations of serum cholinesterase and galectin-3 in predicting poor short-term prognosis of patients with ADHF was 0.858 and 0.752,respectively,while the AUC for predicting poor long-term prognosis were 0.693 and 0.690,respectively. The AUC for the combined determination of serum cholinesterase,galectin-3,NT-proBNP,cTnI and LVEF in predicting poor short-term and long-term prognosis were 0.909 and 0.869,respectively. Conclusions The determination of serum cholinesterase,galectin-3,NT-proBNP,cTnI and LVEF is helpful for predicting the poor short-term and long-term prognosis of patients. The combined determination has a higher predictive value and a higher evaluation value for short-term prognosis than long-term prognosis.

Key words: Cholinesterase, Galectin-3, Acute decompensated heart failure, Prognosis

CLC Number: